Profil
Aneta Ferguson is currently General Counsel & Vice President at Avanir Pharmaceuticals, Inc., a position held since 2015.
Former roles include General Counsel at Adverum Biotechnologies, Inc. from 2024 to 2025, Vice President & Head-Global Legal Affairs at Reneo Pharmaceuticals, Inc., and Vice President & Deputy General Counsel at ARS Pharmaceuticals Operations, Inc. Education includes graduate degrees from the University of California, Los Angeles and Uniwersytet Slaski.
Anciens postes connus de Aneta Ferguson
| Sociétés | Poste | Fin |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Conseiller Juridique Général | 09/12/2025 |
| ONKURE THERAPEUTICS, INC. | Conseiller Juridique Général | - |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Conseiller Juridique Général | - |
| AVANIR PHARMACEUTICALS INC | Conseiller Juridique Général | - |
Formation de Aneta Ferguson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for the treatment of nervous system disorder | Health Technology |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uniwersytet Slaski
Uniwersytet Slaski Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
Reneo Pharmaceuticals, Inc.
Reneo Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases | Health Technology |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Health Technology |
















